Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Inovio Abandons Lassa, MERS Vaccines Shortly After Ending COVID-19 Booster Work

Nov 18 2022

• By Joseph Haas

Halt — Inovio is halting work on two vaccines partnered with CEPI • Source: Shutterstock

Additional Topics

Business Strategies Clinical Trials Vaccines Research & Development Infectious Diseases BioPharmaceutical

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.